Skip to main content
. 2015 Sep 15;17(8):877–884. doi: 10.1093/ehjci/jev228

Table 1.

Patient characteristics

Controls BAV TAV P-value
Controls vs. BAV
P-value
Controls vs. TAV
P-value
TAV vs. BAV
P-value overall
n 65 50 50
Age (years) 43 ± 14 (78, 19) 49 ± 14 (80, 23) 61 ± 14 (85, 26) 0.017 <0.001 <0.001 <0.001
Female 25 (38%) 12 (24%) 9 (18%) 0.101 0.018 0.464 0.041
Height (m) 1.72 ± 0.08 (1.90, 1.52) 1.77 ± 0.08 (1.96, 1.55) 1.61 ± 0.19 (1.93, 1.27) 0.002 0.017 <0.001 <0.001
Weight (kg) 84 ± 19 (136, 54) 83 ± 13 (123, 59) 86 ± 17 (140, 43) 0.561
Effective orifice area (cm2) 2.6 ± 0.5 (1.8, 4.0) 2.0 ± 0.7 (0.9, 3.5) 2.5 ± 0.8 (0.9, 3.9) <0.001 0.65 0.001 <0.001
Stenosis severity
 Mild 0 (0%) 14 (28%) 7 (14%) <0.001 0.002 0.087 <0.001
 Moderate 0 (0%) 3 (6%) 0 (0%) 0.046 0.08 0.03
 Severe 0 (0%) 0 (0%) 0 (0%)
Regurgitation severity
 Mild 0 (0%) 6 (12%) 4 (8%) 0.004 0.021 0.5 0.023
 Moderate 0 (0%) 4 (8%) 7 (14%) 0.021 0.002 0.34 0.011
 Severe 0 (0%) 1 (2%) 1 (2%) 0.317

All continuous data are presented as mean ± standard deviation (max, min) or number (%). P-value resulted from independent-sample t-test (Gaussian distribution) or Mann–Whitney (non-Gaussian distribution) comparing subjects groups.

BAV, bicuspid aortic valve; TAV, tricuspid aortic valve.